The rise of Viagra initially drove a boom for major pharmaceutical companies, nevertheless recent shifts present a complicated picture for investors. Off-patent alternatives are eroding earnings, and continued patent https://henriffuk463092.bloggactif.com/42641805/sildenafil-and-pharma-a-volatile-investment